Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first941 to 960 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| MIR29A microRNA 29a | 407021 HGNC:31616 | 0 | 0 | 0 | 0 | 2,573 | 7,687 |
| HLA-DPB1 major histocompatibility complex, class II, DP beta 1 | 3115 HGNC:4940 | 1 | 116 | 0 | 0 | 3,752 | 7,679 |
| PTHLH parathyroid hormone like hormone | 5744 HGNC:9607 | 1 | 159 | 1 | 1 | 2,981 | 7,677 |
| ATRX ATRX chromatin remodeler | 546 HGNC:886 | 1 | 8 | 0 | 0 | 3,080 | 7,668 |
| TMED2 transmembrane p24 trafficking protein 2 | 10959 HGNC:16996 | 1 | 50 | 0 | 0 | 4,585 | 7,666 |
| COL3A1 collagen type III alpha 1 chain | 1281 HGNC:2201 | 1 | 72 | 2 | 66 | 3,580 | 7,665 |
| ITGAE integrin subunit alpha E | 3682 HGNC:6147 | 1 | 32 | 0 | 0 | 4,886 | 7,664 |
| TYK2 tyrosine kinase 2 | 7297 HGNC:12440 | 1 | 45 | 18 | 774 | 3,831 | 7,661 |
| CETP cholesteryl ester transfer protein | 1071 HGNC:1869 | 1 | 62 | 6 | 39 | 3,450 | 7,659 |
| NFKB2 nuclear factor kappa B subunit 2 | 4791 HGNC:7795 | 1 | 36 | 1 | 4 | 5,014 | 7,641 |
| PCSK1 proprotein convertase subtilisin/kexin type 1 | 5122 HGNC:8743 | 1 | 93 | 0 | 0 | 4,705 | 7,634 |
| CBL Cbl proto-oncogene | 867 HGNC:1541 | 1 | 37 | 0 | 0 | 3,976 | 7,624 |
| RYR2 ryanodine receptor 2 | 6262 HGNC:10484 | 1 | 18 | 0 | 0 | 3,972 | 7,619 |
| CXCR5 C-X-C motif chemokine receptor 5 | 643 HGNC:1060 | 1 | 213 | 0 | 0 | 4,491 | 7,617 |
| ELAVL1 ELAV like RNA binding protein 1 | 1994 HGNC:3312 | 1 | 42 | 0 | 0 | 3,203 | 7,615 |
| FANCB FA complementation group B | 2187 HGNC:3583 | 1 | 22 | 0 | 0 | 3,862 | 7,611 |
| ACTN1 actinin alpha 1 | 87 HGNC:163 | 1 | 74 | 0 | 0 | 5,138 | 7,594 |
| HBA2 hemoglobin subunit alpha 2 | 3040 HGNC:4824 | 1 | 209 | 2 | 27 | 2,347 | 7,592 |
| AICDA activation induced cytidine deaminase | 57379 HGNC:13203 | 1 | 399 | 0 | 0 | 4,408 | 7,581 |
| CFLAR CASP8 and FADD like apoptosis regulator | 8837 HGNC:1876 | 1 | 107 | 0 | 0 | 3,711 | 7,570 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=48
{
"data": {
"total": 193990,
"results": [
{
"id": "407021",
"title": "MIR29A: microRNA 29a",
"summary": "NCBI Gene 407021. 0 proteins, 0 patents, 0 drugs, 0 trials, 2,573 NIH grants and 7,687 papers.",
"record": "/library/genes/407021",
"gene_id": 407021,
"symbol": "MIR29A",
"name": "microRNA 29a",
"hgnc_id": "HGNC:31616",
"counts": {
"proteins": 0,
"patents": 0,
"drugs": 0,
"trials": 0,
"grants": 2573,
"papers": 7687
}
},
{
"id": "3115",
"title": "HLA-DPB1: major histocompatibility complex, class II, DP beta 1",
"summary": "NCBI Gene 3115. 1 protein, 116 patents, 0 drugs, 0 trials, 3,752 NIH grants and 7,679 papers.",
"record": "/library/genes/3115",
"gene_id": 3115,
"symbol": "HLA-DPB1",
"name": "major histocompatibility complex, class II, DP beta 1",
"hgnc_id": "HGNC:4940",
"counts": {
"proteins": 1,
"patents": 116,
"drugs": 0,
"trials": 0,
"grants": 3752,
"papers": 7679
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=49",
"request_id": "oSvMV5iMF423FUDi"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant